View the article online at http://citywire.co.uk/wealth-manager/article/a746341
AA-rated Cross & Fosh buy into 10% slump in tech business
by David Campbell on Apr 15, 2014 at 07:59
Citywire AA-rated star UK equity duo Anthony Cross (pictured) and Julian Fosh have upped their conviction in decontamination and pharmaceutical services business Bioquell following a near 10% fall in shares.
The two managers increased their holding in the business from 3.99 million to 4.21 million or 10.1% worth £5.35 million at a share price of 127p, down 8.54% over the last month.
The shares are held in their £277 million Liontrust UK Smaller Companies fund.
Bioquell slumped almost 10% in mid-March after the company reported profit for 2013 down 22.5% on the same period of the year before, from £4 million to £3.1 million following a ‘tough year’.
Investec cut its price target following the announcement, from 147p to 133p, rated hold.
The fall, which came despite a 9% increase in revenue, followed £900,000 of restructuring and redundancy charges as the company re-orientated its decontamination division toward life sciences.
News sponsored by:
As the UK coalition government strives to rebalance the national economy, so called 'reshoring' looks set to play an increasingly important role in economic recovery.
Today's top headlines
With talk on interest rates on the horizon, our latest roundtable debate covers income investing against a changing backdrop
More about this:
Look up the funds
Look up the shares
Look up the fund managers
On the road